Story perspectives
Aetna Shines with 2026 Medicare Ratings, CVS Stock Surges
10/14/2025
34 4
1 of 1
Story summary
- On October 13, 2025, Centers for Medicare & Medicaid Services released the 2026 Star Ratings for Medicare Advantage Prescription Drug plans.
- Aetna, a subsidiary of CVS Health, has over 81% of its members in plans rated 4 stars or higher.
- Aetna's 2026 plans emphasize access, simplicity, and care, including a $2,100 maximum out-of-pocket for prescription drugs and $0 premium plans.
- CVS Health's stock has risen year to date by 73.5%.
